...
首页> 外文期刊>Journal of experimental orthopaedics. >Association between changes in molecular biomarkers of cartilage matrix turnover and changes in knee articular cartilage: a longitudinal pilot study
【24h】

Association between changes in molecular biomarkers of cartilage matrix turnover and changes in knee articular cartilage: a longitudinal pilot study

机译:软骨基质更新的分子生物学标志物变化与膝关节软骨变化之间的关联:一项纵向试验研究

获取原文
           

摘要

Abstract BackgroundAn early detection of Osteoarthritis is urgently needed and still not possible until today. The aim of the study was to assess whether molecular biomarkers of cartilage turnover are associated with longitudinal change in knee cartilage thickness during a 2 year period in individuals with increased risk of developing knee osteoarthritis. A secondary aim was to assess whether prior knee injury or subjective patient-reported outcomes at baseline (BL) were associated with articular cartilage changes. Nineteen volleyball players (mean age 46.5?±?4.9?years, 47% male) with a 30-year history of regular high impact training were recruited. The serum biomarkers Cpropeptide of type II procollagen (CPII), cartilage oligomeric matrix protein (COMP), collagenase generated carboxy-terminal neoepitope of type II collagen (sC2C), cartilage intermediate layer protein 2 (CILP-2), and the urine biomarkers C-telopeptide of type II collagen (CTX-II) and collagenase-generated peptide(s) of type II collagen (C2C-HUSA) were assessed at BL and at 2 year follow up (FU). Femorotibial cartilage thinning, thickening and absolute thickness change between BL and FU was evaluated from magnetic resonance imaging. Subjective clinical status at BL was evaluated by the International Knee Documentation Committee Subjective Knee Form and the Short-Form 36 Physical Component Score.ResultsCILP-2 was significantly higher at FU and linearly associated with the absolute cartilage thickness change during the experimental period. Prior injury was a predictor of increased absolute cartilage thickness change.ConclusionMeasuring the change in the cartilage biomarker CILP-2 might be a valid and sensitive method to detect early development of knee osteoarthritis as CILP-2 appears to be related to cartilage thickness loss in certain individuals with increased risk of developing knee osteoarthritis. Prior knee injury may be predictive of increased articular cartilage thickness change.
机译:摘要背景迫切需要早期发现骨关节炎,直到今天仍然无法实现。这项研究的目的是评估在发生膝骨关节炎的风险增加的个体中,软骨转换的分子生物标志物在2年内是否与膝软骨厚度的纵向变化相关。第二个目的是评估先前的膝关节损伤或基线时患者主观报告的结局(BL)是否与关节软骨变化相关。招募了19名具有30年定期高强度训练历史的排球运动员(平均年龄46.5±4.9岁,男性47%)。血清II型胶原原生物标志物(CPII),软骨寡聚基质蛋白(COMP),胶原酶生成的II型胶原的羧基末端新表位(sC2C),软骨中间层蛋白2(CILP-2)和尿液生物标志物C在BL和2年随访(FU)时评估II型胶原的端肽(CTX-II)和胶原酶生成的II型胶原的肽(C2C-HUSA)。通过磁共振成像评估BL和FU之间的前腓软骨变薄,增厚和绝对厚度变化。国际膝关节文献委员会主观膝关节形式和短形式36物理成分评分评估了BL的主观临床状态。结果CILP-2在FU时明显更高,并且在实验期间与绝对软骨厚度变化呈线性关系。结论:测量软骨生物标志物CILP-2的变化可能是检测膝骨关节炎早期发展的有效且灵敏的方法,因为CILP-2似乎与某些部位的软骨厚度减少有关。患膝骨关节炎的风险增加的个体。先前的膝盖受伤可能预示着关节软骨厚度变化的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号